Rtw Investments, LP Biomea Fusion, Inc. Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.39 - $9.03 $2.61 Million - $5.36 Million	-593,846 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.22 - $12.72 $1.71 Million - $3.01 Million	-236,948 Reduced 28.52%	593,846 $4.42 Million
Q2 2021 Aug 13, 2021	BUY	$13.65 - $20.93 $11.3 Million - $17.4 Million	830,794 New	830,794 $12.3 Million

103

17.8M

262K

354K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $48.3M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.